Home Longevity market intelligence Senotherapeutics (download)

Senotherapeutics (download)


Sold By: Longevity.Technology
SKU: MISS Category:

Removing senescent cells to drive human longevity: a key sector for longevity, we address the 4 subsets of senotherapeutics

Published July 2021

Additional information

End user license agreement

Purchase Single-User License: to open the report you will be required to insert the same email address that you have used to purchase the report.

First Longevity grants you a worldwide, non-exclusive, non-transferable license to:

(i) download, store and display one electronic copy of the Product in machine-readable form; and (ii) print additional paper copies of the Product for internal business use within your organisation, provided that First Longevity is, in each case, cited as the source of the Product. Notwithstanding the foregoing, you shall NOT be permitted to:

(a) transmit (including, but not limited to, by email) to, or permit any, third-party to use and/or gain access to an electronic copy of the Product;

(b) resell, sub-license, rent, lease, transfer or attempt to assign the rights in the Product (in whole or in part) to any third party;

(c) modify or alter the Product or create a database in electronic or structured manual form by systematically downloading and storing any of the content from such Product other than for internal business purposes;

(d) download, store, reproduce, transmit, display, copy, distribute, commercially exploit or use the Product other than as expressly permitted above; and

(e) use the Product in any manner that would contravene the terms and conditions contained in these License Terms or that would contravene laws in England & Wales, or in any other jurisdiction.

We respect copyright and trust that you do too: thank you!

Why read this report?

The total market value of diseases that could be addressed with (eventual) senotherapeutic therapies totals over $127B.

This new report from Longevity.Technology’s Market Intelligence Unit assesses the investment potential of the emerging senotherapeutics sector, examines the potential of targeting cell senescence to treat many major diseases, and deep-dives into key companies working in the field, including:

Atropos Therapeutics; Cleara Biotechnology; Insilico Medicine; Oisin Biotechnologies; Rockfish Bio; Rubedo Life Sciences; and TAmiRNA.

The report identifies the opportunities for growth in the senotherapeutics market and the factors that will drive that growth, together with the challenges that this early market will encounter as it moves into scale and validation.

Aubrey de Grey, Chief Science Officer and Co-founder, SENS Foundation: “This thorough report from Longevity.Technology’s market intelligence unit provides important insights for the senotherapeutic market and highlights key concepts for potential investors, product developers, market entrants and academics.”

Who this report is for?

The complete senotherapeutics market intelligence report is for:

1. Investors seeking clarity on investment opportunities, market dynamics and risk factors;

2. Senotherapeutic innovators looking to better understand the opportunities and challenges senotherapeutics face;

3. Existing senotherapeutic companies looking to secure investment for future funding rounds;

4. Investors seeking information on the different types of senotherapeutics and the strengths and weaknesses of each;

5. Clinicians looking for an educational resource to learn about up-and-coming aspects of senotherapeutics;

6. Executives of large pharmaceuticals to evaluate their participation in the longevity economy.


  1. What is your returns/cancellation policy? If you are not satisfied with the report we would like to understand why ahead of refunding you, we want you to be 100% satisfied: we learn through feedback.
  2. Is the price excluding tax – Yes. Sales tax/VAT is applied based on your region and in accordance with our UK-status.
  3. How long until I get my delivery?  – Being a digital service, you get access to the report instantly after purchase if it has been published. If you have pre-ordered we will email you on the day of release so that you can login and then download.
  4. Are my payment details/data secure? – Yes, all transactions are securely carried out; our Stripe payment systems are always aligned to the latest security standards.
  5. Can I re-download the document? – Yes. During your purchase, you will be asked to create an account with us. Post purchase, you will be able to login and download it as many times as you want.


There are no reviews yet.

Be the first to review “Senotherapeutics (download)”

You may also like…